Abstract
The recent emphasis on the development of non-viral transfection agents for gene delivery has led to new physics and chemistry-based techniques, which take advantage of charge interactions and energetic processes. One of these techniques which shows much promise for both in vitro and in vivo transfection involves the use of biocompatible magnetic nanoparticles for gene delivery. In these systems, therapeutic or reporter genes are attached to magnetic nanoparticles, which are then focused to the target site/cells via high-field/high-gradient magnets. The technique promotes rapid transfection and, as more recent work indicates, excellent overall transfection levels as well. The advantages and difficulties associated with magnetic nanoparticle-based transfection will be discussed as will the underlying physical principles, recent studies and potential future applications.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pankhurst QA, Connoly J, Jones SK, Dobson J . Applications of magnetic nanoparticles in biomedicine. J Phys D 2003; 36: R167–R181.
Grief AD, Richardson G . Mathematical modelling of magnetically targeted drug delivery. J Magn Magn Mater 2005; 293: 455–463.
Neuberger T, Schopf B, Hofmann H, Hofmann M, von Rechenberg B . Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. J Magn Magn Mater 2005; 293: 483–496.
Harris LA, Goff JD, Carmichael AY, Riffle JS, Harburn JJ, St Pierre TG et al. Magnetite nanoparticle dispersions stabilized with triblock copolymers. Chem Mater 2003; 15: 1367–1377.
Yiu HPH, El Haj AJ, Dobson J . Novel iron oxide-silica nanostructured particles for cell biology. Vienna Magnetics Group Report 2005, 14–15 pp. ISBN 3-902105-00-1.
Yiu HPH, Dobson J, El Haj AJ . Internalization of functionalized magnetic nanoparticles into human cells with the use of DOTAP as a transfecting agent. Vienna Magnetics Group Report 2005, 176–177 pp. ISBN 3-902105-00-1.
Cai D, Mataraza JM, Qin ZH, Huang Z, Huang J, Chiles TC et al. Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing. Nature Methods 2005; 2: 449–454.
Morishita N, Nakagami H, Morishita R, Takeda S-i, Mishima F, Terazono B et al. Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. Biochem Biophys Res Comm 2005; 334: 1121–1126.
Plank C, Schillinger U, Scherer F, Bergemann C, Remy JS, Krotz F et al. The magnetofection method: using magnetic force to enhance gene therapy. Biol Chem 2003; 384: 737–747.
Gersting SW, Schillinger U, Lausier J, Nicklaus P, Rudolph C, Plank C et al. Gene delivery to respiratory epithelial cells by magnetofection. J Gene Med 2004; 6: 913–922.
Krötz F, Sohn HY, Gloe T, Plank C, Pohl U . Magnetofection potentiates gene delivery to cultured endothelial cells. J Vasc Res 2003; 40: 425–434.
Schillinger U, Brill T, Rudolph C, Huth S, Gersting SW, Krötz F et al. Advances in magnetofection – magnetically guided nucleic acid delivery. J Magn Magn Mater 2005; 293: 501–508.
Krötz F, de Wit C, Sohn H-Y, Zahler S, Gloe T, Pohl U et al. Magnetofection – a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo. Mol Ther 2003; 7: 700–710.
Krötz F, Engelbrecht B, Buerkle MA, Bassermann F, Bridell H, Gloe T et al. The tyrosine phosphatase, SHP-1, is a negative regulator of endothelial superoxide formation. J Amer Coll Cardiol 2005; 45: 1700–1706.
Huth S, Lausier J, Gersting SW, Rudolph C, Plank C, Welsch U et al. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J Gene Med 2004; 6: 923–936.
Ferrari S, Griesenbach U, Shirai-Iida T, Shu T, Hironaka T, Hou X et al. A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo. Gene Therapy 2004; 11: 1654–1656.
Acknowledgements
I am supported by a Wolfson Foundation – Royal Society Research Merit award for this study. I thank the UK Cystic Fibrosis Gene Therapy Consortium & The Cystic Fibrosis Trust for funding support. Professor Eric Alton, Dr Uta Griesenbach, Dr Stefania Xenariou and Dr Stuart McBain are thanked for their helpful discussions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dobson, J. Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther 13, 283–287 (2006). https://doi.org/10.1038/sj.gt.3302720
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3302720
Keywords
This article is cited by
-
Magnetically retrievable nanocatalyst Fe3O4@CPTMO@dithizone-Ni for the fabrication of 4H-benzo[h]chromenes under green medium
Scientific Reports (2023)
-
Himalayan Fern Cheilanthes bicolor Mediated Fabrication and Characterization of Iron Nanoparticles with Antimicrobial Potential
BioNanoScience (2022)
-
Multifunctional nanodiamonds as emerging platforms for cancer treatment, and targeted delivery of genetic factors and protein medications—a review
Journal of Materials Science (2022)
-
Role of Nanoscale Delivery Systems in Tissue Engineering
Current Pathobiology Reports (2021)
-
Magnetic Nanostructures for Cancer Theranostic Applications
Current Pathobiology Reports (2021)